# Propofol {#id}

Propofol (2-6 di-isopropylphenol) is a phenolic derivative with effects on many receptors including:
* GABA<sub>A</sub>  
Potentiates the effect of GABA, prolonging Cl<sup-</sup> channel opening and hyperpolarising the cell.
* Glycine
* Nicotinic ACh
* D<sub>2</sub> receptors


|Property|Action|
|--|--|
|**Class**|Phenolic derivative|
|**Uses**|Induction of anaesthesia, sedation, TIVA|
|**Presentation**| White oil-in-water emulsion at a **pH of 7-8.5** containing:<br>- 10-20mg.ml<sup>-1</sup> propofol<br>- 10% soybean oil (solubilising agent)<br>- 1.2% Purified egg phosphatide (emulsifier) <br>- 2.25% glycerol (for tonicity)<br>Bacteriostatic additives including:<br>- Generics: sodium metabisulphate<br>- Diprivan: disodium edetate (less allergenic)<br>  Risk of bacterial contamination limits shelf life.<br> Energy content is 1.1kcal.ml<sup>-1</sup>|
|**pKa**| 11 - almost all is unionised (and active) at physiologic pH|
|**Route of Administration**|IV only|
|**Dosing**|Induction: 1-2.5mg.kg<sup>-1</sup> Maintenance: 4-12mg/kg/hr. Target plasma concentration of 4-8μg.ml<sup>-1</sup> to maintain general anaesthesia|
|**Distribution**|98% protein bound. Very high V<sub>D</sub> at 4L.kg<sup>-1</sup>. Rapid initial distribution: t<sub>1/2</sub>α (fast) 1-3 minutes, intermediate distribution t<sub>1/2</sub>α (slow) 30-70 minutes. t<sub>1/2<sub>ke0</sub></sub> of **2.7** min.|
|**Metabolism**| Hepatic and extra-hepatic metabolism to inactive glucuronides and sulphates; t<sub>1/2</sub>β 2-12 hours. **Clearance** of <strong>30-60ml.kg.min<sup>-1</sup></strong>, unaffected by renal and hepatic disease. Context sensitive half-time peaks at **50 minutes** following a 9 hour infusion.|
|**Elimination**|Tri-exponential. Renal elimination of inactive metabolites.|
|**Resp**|Respiratory depression, apnoea. Strong suppression of laryngeal reflexes. ↓ Response to hypoxia and hypercapnoea. Bronchodilation.
|**CVS**|↓ Arterial and venous vasodilation (via stimulating NO release) causing ↓ SVR and ↓ VR, with ↓ BP. ↓ Inotropy via ↓ in SNS tone, ↓ MVO<sub>2</sub>. Depresses baroreceptor reflex. Pain on injection due to lipid emulsion.|
|**CNS**|Hyponosis. Rapid LoC (within 1 arm-brain ciruclation time). ↓ CMRO2, CBF, and ICP. Anticonvulsant. ↓ IOP. Parodoxical excitatory effects seen in ~10% - dystonic movements of subcortical origin. EEG demonstrates non-specific seizure-like activity.|
|**MSK**|Pain on injection into small veins|
|**Renal**|Green urine|
|**GIT**|Anti-emetic. ↓ Hepatic Blood Flow|
|**Metabolic**|Fat overload syndrome, lipaemia following prolonged infusion|
|**Toxic Effects**|Propofol infusion syndrome: Acidosis, bradycardia, and MODS following prolonged infusion (>24 hours), particularly with high doses (>4mg.kg<sup>-1</sup>.hr<sup>-1</sup>), and in children.|


---
##References
Peck and Hill
CICM July/Sept 2007
http://ceaccp.oxfordjournals.org/content/4/3/76.full.pdf